The estimated Net Worth of Siddhartha Kadia is at least $22.5 Tisíc dollars as of 28 May 2022. Dr Kadia owns over 3,739 units of Berkeley Lights stock worth over $4,487 and over the last 4 years he sold BLI stock worth over $0. In addition, he makes $17,967 as CEO & Director at Berkeley Lights.
Dr has made over 1 trades of the Berkeley Lights stock since 2022, according to the Form 4 filled with the SEC. Most recently he exercised 3,739 units of BLI stock worth $4,487 on 28 May 2022.
The largest trade he's ever made was exercising 3,739 units of Berkeley Lights stock on 28 May 2022 worth over $4,487. On average, Dr trades about 267 units every 0 days since 2021. As of 28 May 2022 he still owns at least 3,739 units of Berkeley Lights stock.
You can see the complete history of Dr Kadia stock trades at the bottom of the page.
Dr. Siddhartha Chandrakant Kadia B.E., M.S., Ph.D. is the CEO & Director at Berkeley Lights.
As the CEO & Director of Berkeley Lights, the total compensation of Dr D at Berkeley Lights is $17,967. There are 2 executives at Berkeley Lights getting paid more, with Dr. Eric D. Hobbs Ph.D. having the highest compensation of $540,025.
Dr D is 51, he's been the CEO & Director of Berkeley Lights since . There are 1 older and 4 younger executives at Berkeley Lights. The oldest executive at Berkeley Lights, Inc. is Stuart L. Merkadeau, 60, who is the Gen. Counsel.
Siddhartha's mailing address filed with the SEC is C/O NUVASIVE, INC., 12101 AIRPORT WAY, BROOMFIELD, CO, 80021.
Over the last 4 years, insiders at Berkeley Lights have traded over $204,033,733 worth of Berkeley Lights stock and bought 177,704 units worth $1,660,642 . The most active insiders traders include Michael E Marks, Gregory T Lucier a John R Chiminski. On average, Berkeley Lights executives and independent directors trade stock every 13 days with the average trade being worth of $83,843. The most recent stock trade was executed by James Paul Mc Claskey on 20 October 2022, trading 122 units of BLI stock currently worth $243.
Berkeley Lights, Inc., a digital cell biology company, focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software. It serves in North America, the Asia Pacific, and Europe. Berkeley Lights, Inc. was incorporated in 2011 and is headquartered in Emeryville, California.
Berkeley Lights executives and other stock owners filed with the SEC include: